Our business was established by Heiner Völk (CEO) in Germany in 2011. The services focus predominantly on consulting and interim management in the life science sector. Clients originate from biotech, pharma and diagnostics industry. Other clients are either providers of services to these industries or investors. Our customers range from small virtual companies to large multinationals in Germany and other countries. The vast majority of our clients, however, prefer to remain undisclosed.

Previous business deployments led Heiner Völk to Germany, Switzerland, USA, UK, France, Austria and the Netherlands. Some of the previous projects concerned the development and/or the business side of therapies in oncology, viral, bacterial or parasitic infectious diseases, and rare diseases. Others concerned the development and/or the business side of vaccines, immuno-therapies, advanced therapy medicinal products (ATMP), in-vitro diagnostics (IVD) and companion diagnostics (CDx). Heiner Völk was involved in several licensing deals.

Furthermore, as an add-on we provide coaching in the business and the private sector.

Before starting his own business in 2011, Heiner Völk was Head of Business Development and member of a management team. Overall he held management positions with increasing responsibilities in four biopharmaceutical companies across a period of 12 years.

During the 12 years prior to switching to the business side in 1999, Heiner Völk conducted research in immunology, oncology and infectious diseases mainly in San Francisco (USA), Brighton (UK), Basel (Switzerland) and Martinsried near Munich (Germany). 

Heiner Völk holds a post-graduate MSc focusing on specialized management in drug development, a PhD (immunology) and another MSc (biochemistry, cell and microbiology).
Heiner Völk is a member of the Pharma Licensing Club Germany (PLCD). When he was active as a scientist he was awarded four highly competitive fellowships.